UBS initiates Pandora stock with Sell rating on growth concerns

UBS initiated coverage on Pandora (PNDORA) with a Sell rating and a DKK950.00 price target, despite acknowledging the company's successful turnaround and attractive fundamentals. The firm cited concerns over normalizing sales momentum, potential margin pressure, and market underestimation of downside risks in US volumes and retail operating leverage. UBS's EBIT estimates for 2025-2027 are notably below consensus, anticipating a slowing earnings trajectory that could pose de-rating risks for the stock.

Analysis

UBS has initiated coverage on Pandora A/S with a Sell rating and a DKK 950.00 price target, presenting a contrarian view despite acknowledging the company's successful operational turnaround and structurally attractive fundamentals. The bank's bearish thesis is predicated on several forward-looking risks, including the normalization of sales momentum, which is expected to create margin pressure. UBS contends that the market is underestimating downside volume risks, particularly as the key US market moderates, and is overly optimistic about the operating leverage potential of Pandora's retail business. This skepticism is quantified by the firm's EBIT estimates, which are 2%, 7%, and 8% below consensus for 2025, 2026, and 2027, respectively. The core concern is that a slowing earnings trajectory will expose the stock to significant de-rating risk, where its valuation multiple contracts.

Key Decisions for Investors

• Investors should weigh UBS's forward-looking concerns about slowing growth against the company's acknowledged recent success and strong business fundamentals.
• Monitor upcoming earnings reports closely for any signs of moderating US sales volumes or margin compression, as these are the central pillars of the bearish thesis.
• Consider the potential for valuation multiple contraction, as UBS's below-consensus EBIT forecasts for 2026 and 2027 suggest a significant risk of de-rating if their projections materialize.